For Sale: the Book of Life

Scholars and entrepreneurs enter brave new world of the human genome

In late June, newspapers heralded the end of a race between giants. Celera Genomics, a two-year-old company with a thick wallet, had sprinted to a tie with a publicly financed consortium of institutions that had been laboring since 1990 to spell out the sequence of chemical letters in


Digital or Print Subscription

Already have an account? Log In Now.